Fulgent Genetics Inc
Ownership
Ownership Structure
Who owns Fulgent Genetics Inc (FLGT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 60.7% of the shares are freely tradable; institutional investors hold 63.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 10.08 | 2,774,519 | -6.3 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 4.68 | 1,289,000 | +82.8 | 03/31/2026 |
| Acadian Asset Management LLC | 4.48 | 1,233,951 | +1,481.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.20 | 880,150 | +0.0 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 2.27 | 625,355 | -6.9 | 06/30/2026 |
| Invenomic Capital Management, LP | 2.22 | 610,318 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.12 | 584,207 | +15.0 | 03/31/2026 |
| Ameriprise Financial Inc | 2.05 | 563,375 | +12.8 | 03/31/2026 |
| State Street Corp | 1.92 | 529,399 | +7.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.01 | 551,839 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer | 986,117 | 21,398,739 $ | Sep 2, 2026 | direct |
| Hsieh Ming | Chief Executive Officer | 885,952 | 19,225,158 $ | Sep 1, 2026 | direct |
| Xie Jian | President and COO | 359,924 | 7,810,351 $ | Sep 2, 2026 | direct |
| Kim Paul | CFO and Treasurer | 356,543 | 7,736,983 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Xie Jian | President and COO | Sell | 2,127 | 19.66 | 41,809 |
| Sep 2, 2026 | Gao Hanlin | Chief Scientific Officer | Sell | 1,673 | 19.66 | 32,885 |
| Sep 1, 2026 | Hsieh Ming | Chief Executive Officer | Other | 4,392 | 19.59 | 86,039 |
| Sep 1, 2026 | Kim Paul | CFO and Treasurer | Other | 2,087 | 19.59 | 40,884 |
| Aug 27, 2026 | Xie Jian | President and COO | Sell | 1,193 | 19.91 | 23,747 |
| Aug 27, 2026 | Gao Hanlin | Chief Scientific Officer | Sell | 939 | 19.91 | 18,691 |
| Aug 26, 2026 | Hsieh Ming | Chief Executive Officer | Other | 2,949 | 19.81 | 58,420 |
| Aug 26, 2026 | Kim Paul | CFO and Treasurer | Other | 1,168 | 19.81 | 23,138 |
| Jul 26, 2026 | Kim Paul | CFO and Treasurer | Other | 2,747 | 19.67 | 54,033 |
| Jul 26, 2026 | Xie Jian | President and COO | Other | 4,361 | 19.67 | 85,781 |
| Jul 26, 2026 | Gao Hanlin | Chief Scientific Officer | Other | 1,645 | 19.67 | 32,357 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.